Literature DB >> 22329648

Progressive and unconventional pharmacotherapeutic approaches to Alzheimer's disease therapy.

Stuart Maudsley, Wayne Chadwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22329648      PMCID： PMC5915359          DOI： 10.2174/156720512799015082

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN： 1567-2050            Impact factor:   3.498


× No keyword cloud information.
  39 in total

1.  Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease.

Authors:  K Une; Y A Takei; N Tomita; T Asamura; T Ohrui; K Furukawa; H Arai
Journal:  Eur J Neurol       Date:  2010-08-18       Impact factor: 6.089

Review 2.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

Review 3.  Systems biology of mammalian circadian clocks.

Authors:  Hideki Ukai; Hiroki R Ueda
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 4.  Androgens, andropause and neurodegeneration: exploring the link between steroidogenesis, androgens and Alzheimer's disease.

Authors:  K A Bates; A R Harvey; M Carruthers; R N Martins
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  Inflammation and Alzheimer's disease.

Authors:  Young-Jung Lee; Sang Bae Han; Sang-Yoon Nam; Ki-Wan Oh; Jin Tae Hong
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

6.  Protective effect of isoflavones against homocysteine-mediated neuronal degeneration in SH-SY5Y cells.

Authors:  Youn-Jin Park; Yumi Jang; Young Hye Kwon
Journal:  Amino Acids       Date:  2010-03-04       Impact factor: 3.520

7.  Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.

Authors:  Michael Schöll; Ove Almkvist; Nenad Bogdanovic; Anders Wall; Bengt Långström; Matti Viitanen; Agneta Nordberg
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses.

Authors:  Noel G Faux; Craig W Ritchie; Adam Gunn; Alan Rembach; Andrew Tsatsanis; Justin Bedo; John Harrison; Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Martin Ingelsson; Colin L Masters; Rudolph E Tanzi; Jeffrey L Cummings; Caroline M Herd; Ashley I Bush
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 9.  Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration.

Authors:  Liyun Wang; Wayne Chadwick; Sung-Soo Park; Yu Zhou; Nathan Silver; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

Review 10.  Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials.

Authors:  Eef Hogervorst; Stephan Bandelow
Journal:  Maturitas       Date:  2010-03-04       Impact factor: 4.342
View more
  3 in total

Review 1.  The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

Authors:  Hanne Leysen; Deborah Walter; Lore Clauwaert; Lieselot Hellemans; Jaana van Gastel; Lakshmi Vasudevan; Bronwen Martin; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

2.  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Krishnan M Dhandapani; Hedy Folkersma; Roger F Butterworth; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

3.  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.

Authors:  Tracey A Ignatowski; Robert N Spengler; Edward Tobinick
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.